The excitotoxicity induced by excessive activation of the glutamatergic neurotransmission pathway is involved in several neuropathologies. In this sense, molecules that prevent the release of glutamate or the excessive activation of its receptors can be useful in preventing the neuronal cell death observed in these diseases. Lectins are proteins capable of reversible binding to the carbohydrates in glycoconjugates, and some have been used in the study and purification of glutamate receptors. ConBr is a mannose/ glucose-binding lectin purified from Canavalia brasiliensis seeds. In the present study, we aimed to evaluate the neuroprotective activity of ConBr against glutamate-induced excitotoxicity. Hippocampal slices were isolated from adult male mice and incubated for 6 h in Krebs saline/DMEM buffer alone (control), in the presence of glutamate or glutamate plus ConBr. The phosphorylation of Akt and mitogen activated protein kinases (MAPKs) such as ERK1/2, p38 MAPK and JNK1/2/3 was evaluated with western blotting.
Introduction
Sugar chains, which are present in glycoproteins, are constituents of biological membranes that can act as biosignaling molecules (Dube and Bertozzi, 2005) influencing a variety of cell signaling pathways (Greengard, 2001; Thomas and Huganir, 2004; Wong and Scott, 2004) . Therefore, carbohydrates can perform key roles in the development, neuroplasticity and synaptic modulation of the central nervous system (CNS) (Matthies et al., 1999; Dube and Bertozzi, 2005; Endo, 2005) . The information contained in the structure of oligosaccharides conjugated to proteins or lipids on the cell surface is recognized by a specialized group of proteins named lectins (Sanz-Aparicio et al., 1997) .
Lectins are a heterogeneous group of proteins capable of reversible binding to carbohydrates and glycoconjugates and thus regulating several physiological and pathological events (Dube and Bertozzi, 2005; Liu and Rabinovich, 2005) . In the CNS, synapses are sites that are rich in carbohydrates (Rambourg and Leblond, 1967) . Moreover, it has been shown that glycoproteins present in the synaptic region are potentially involved in regulating synaptic activity (Gurd, 1989; Wing, 1993) . Nevertheless, except for galectin-1, a lectin expressed in the CNS that displays galactose affinity, few lectins have been isolated and characterized concerning their potential roles in neural tissue (Ghazarian et al., 2010; Yamane et al., 2010) .
Lectins with mannose/glucose affinity obtained from plants, such as concanavalin A (ConA), a lectin extracted from the seeds of Canavalia ensiformis, have been employed as tools to study neuroplasticity (Lin and Levitan, 1991; Scherer and Udin, 1994) , to isolate and study synaptic glycoproteins (Partin et al., 1993; Fay and Bowie, 2006) , to study neurotransmitter release (Boehm and Huck, 1998) and to study monoamine receptors and transporters (Cedeñ-o et al., 2005) . Furthermore, it has been shown that ConA is able to bind and modulate glutamatergic receptors (Yue et al., 1995; Fay and Bowie, 2006) .
ConBr is a lectin with an affinity for mannose/glucose isolated from the Brazilian bean C. brasiliensis. The sequence and crystallographic structure of ConBr has been defined, and the amino acid sequence displays a 99% homology with ConA (Sanz-Aparicio et al., 1997; Cavada et al., 2001) . The biological effects of ConBr in peripheral tissues include the stimulation of histamine release in mast cells (Lopes et al., 2005) , the stimulation of nitric oxide production in macrophages (Andrade et al., 1999) and the activation of apoptosis in lymphocytes . Despite these actions and the structural similarity between ConBr and ConA , the biological effects of ConBr on neural cells and its role in the CNS have not been well studied.
Our group previously demonstrated that ConBr, but not ConA, presents an antidepressant-like action via the activation of the monoaminergic system; this action was assessed in mice with the forced swimming test (Barauna et al., 2006) . Moreover, in a recent study we showed that ConBr may act as a potential inhibitor of N-methyl-D-aspartate (NMDA) receptor activation, possibly counteracting the calcium influx gated by this ionotropic glutamate receptor. ConBr was able to block the seizures, the cell death, the activation of the AMPA subtype of glutamate receptors and the JNK2/3 phosphorylation induced by quinolinic acid, a synthetic agonist of the NMDA receptor (Russi et al., 2012) .
Glutamate is the major excitatory neurotransmitter in the CNS of mammals; however, an excess of glutamate in the synaptic cleft may be toxic to neural cells, inducing cell death as a result of the excessive influx of Ca 2+ (Choi, 1987; Bonfoco et al., 1995; Meldrum, 2000; Lynch and Guttmann, 2002) . Due to the NMDA receptor's high permeability to Ca 2+ and incomplete desensitization, this receptor is considered to be the main mediator of glutamatergic excitotoxicity (Choi, 1992; Rothstein, 1996; Gonda, 2012) . The mechanisms of cell death in response to glutamatergic excitotoxicity are unclear but are likely to involve the release of apoptotic factors, the activation of mitogen activated protein kinases (MAPKs) (Schwarzschild et al., 1997; Yang et al., 1997; Molz et al., 2008b) and the inhibition of the PI3K/AKT pathway (Chuang et al., 2011; Molz et al., 2011; Sun et al., 2012) . Extracellular signal-regulated kinases (ERK1/2), c-Jun N-terminal kinases (JNK1/2/3) and p38
MAPK are serine-threonine kinases and members of the MAPKs family that are modulated in response to a variety of extracellular signals including growth factors, cytokines and neurotransmitters. They are involved in the processes of neurodevelopment and neuroplasticity because they mediate various cellular responses, such as proliferation, differentiation, synaptic activity, cell survival and cell death (Chen et al., 2001; Chu et al., 2004; Thomas and Huganir, 2004; Sweatt, 2004; Waetzig and Herdegen, 2004; Kim and Choi, 2010) . The phosphatidylinositol 3-kinase (PI3K)/Akt (or PKB) pathway can also be modulated by growth factors and neurotransmitters, and its activation plays a central role in the regulation of cell growth, proliferation, metabolism, cell survival and neuroplasticity (Hanada et al., 2004; Brazil et al., 2004; Van Der Heide et al., 2006) . It is noteworthy that the inhibition of p38 MAPK (Molz et al., 2008b) , the knockdown of JNK3 (Yang et al., 1997; Bogoyevitch et al., 2010) and the activation of PI3K/AKT (Piermartiri et al., 2009; Chuang et al., 2011; Molz et al., 2011; Lee et al., 2012; Sun et al., 2012) all result in a neuroprotective effect against glutamate excitotoxicity. Moreover, the selective NMDA receptor antagonist dizocilpine maleate (MK-801), promoted cell survival and increased the phosphorylation of Akt. Taking all these aspects together, the present study was designed to investigate the neuroprotective capacity of ConBr in an in vitro model of glutamatergic excitotoxicity on hippocampal slices. Moreover, we aimed to establish the putative involvement of the MAPKs and the PI3K/Akt pathway in the neuroprotective mechanism displayed by ConBr. Our results reinforce previous data that indicate that the neuroprotective potential of ConBr is dependent on the carbohydrate recognition domain (CRD) interaction. Moreover, the present data show, for the first time, that ConBr can counteract glutamate excitotoxicity by a mechanism dependent on PI3K/Akt activation.
Materials and methods

Chemicals
The anti-phospho-ERK1/2, anti-phospho-JNK1/2/3, anti-phospho-Akt and anti-total-AKT antibodies as well as the LumiGLO chemiluminescent substrate, were purchased from Cell Signaling (Beverly, MA, USA). The anti-phospho-p38 MAPK , anti-total-p38 MAPK , anti-total-ERK1/2 and anti-total-JNK1/2 antibodies, as well as the PI3K inhibitor LY294002, were obtained from Sigma (St. Louis, MO, USA). The goat anti-rabbit IgG HRP (horseradish peroxidase)-conjugated secondary antibody was obtained from Millipore (Billerica, MA, USA). The Dulbecco's modified Eagle's medium (DMEM) was purchased from Gibco Ò . Tris and b-mercaptoethanol were obtained from Amresco (Solon, OH, USA). The MTT, SDS, and bisacrylamide were from USB (Cleveland, OH, USA). Acrylamide, Hyperfilm™, and Hybond™ nitrocellulose were purchased from GE Healthcare Life Sciences (Piscataway, NJ, USA). All of the other reagents were of high analytical grade.
Animals
Male adult Swiss mice (approximately 50 days old and weighing between 30 and 40 g) were provided by the Universidade Federal de Santa Catarina (UFSC, Brazil) breeding colony. The mice were housed in plastic cages with food and water available ad libitum and maintained in an air-conditioned room (22 ± 1°C) on a 12 h light/dark cycle. The animals were treated, manipulated and euthanized according to the ''Principles of Laboratory Animal Care'' (NIH publication no. 80-23, revised 1996) , and the experiments were approved by the Committee on the Ethics of Animal Experiments of the Federal University of Santa Catarina (CEUA/UFSC; www.ceua.ufsc.br; Permit Number PP00345). All efforts were made to minimize the number of animals used and animal suffering.
Lectin purification
The C. brasiliensis lectin was purified by classical methods, including precipitation with ammonium sulfate and affinity chromatography on a Sephadex-G-50 column. The homogeneity of all lectin preparations was monitored by SDS-PAGE, as described previously (Moreira and Cavada, 1984; Cavada et al., 2001 ).
Preparation of hippocampal slices
The preparation and treatment of hippocampal slices were performed as previously described (Cordova et al., 2004; Molz et al., 2008a) . Briefly, the animals were euthanized by decapitation, their encephala were extracted and the hippocampi were immediately dissected (at 4°C) in Krebs-Ringer bicarbonate buffer (KRB) (122 mM NaCl, 3 mM KCl, 1.2 mM MgSO 4 , 1.3 mM CaCl 2 , 0.4 mM KH 2 PO 4 , 25 mM NaHCO 3 and 10 mM D-glucose). The buffer was bubbled with a mixture of 95% O 2 and 5% CO 2 up to pH 7.4. Slices of 400 lm thickness were prepared using a McIlwain tissue chop-per. The slices were individually pre-incubated with KRB (300 ll/ slice) for 30 min at room temperature (RT). For the treatments, the medium was replaced with a nutritive incubation medium composed of 50% KRB, 50% Dulbecco's modified Eagle's medium (DMEM), 20 mM HEPES and 100 lg/ml of gentamicin, and the samples were incubated at 37°C in a 95% O 2 /5% CO 2 atmosphere. The treatments were divided into four groups: control (KRB/DMEM), glutamate, ConBr and glutamate co-administered with ConBr. In another set of experiments, the PI3K inhibitor LY294002 (10 lM) was added during the 30 min of pre-incubation and during the 6 h of treatment.
Cell viability
The viability of the cells in the slices was analyzed with the colorimetric MTT [3 0 -(4,5-dimethylthiazol-2yl) 2,5-diphenyltetrazolium bromide] reduction assay (Liu et al., 1997) . After the treatments, the medium was removed, and the slices (in triplicates) were incubated with 0.5 mg/ml MTT (200 ll) in KRB. The slices were incubated for 20 min at 37°C. The mitochondrial dehydrogenases in viable cells reduce the MTT to formazan crystals, which were dissolved in dimethylsulfoxide (DMSO). The absorbance was measured spectrophotometrically using a microplate reader (k = 540 nm). The results were expressed as a percentage of the control (non-treated slices). In addition, the hippocampal slices stained with the MTT formazan crystals and not solubilized with DMSO were visualized with optical microscopy using an inverted NIKON eclipse T2000-U microscope.
Western blotting analysis
After the treatments, the hippocampal slices were solubilized in sample buffer (200 mM Tris, 40 mM EDTA, 4% SDS, pH 6.8) and immediately boiled for 5 min. After homogenization, an aliquot was removed to determine the protein concentration with the method described by Peterson (1977) , and the concentration was calculated using a standard curve with bovine serum albumin. Next, sample dilution solution (1:4 vol/vol; 40% glycerol, 50 mM Tris containing minimal bromophenol blue) and b-mercaptoethanol (for a final concentration of 8%) were added to each sample. The samples (60 lg of total protein/track) were electrophoresed on 10% SDS-PAGE minigels. The proteins were then transferred to a nitrocellulose membrane using a semidry blotting apparatus (TE 70 SemiPhor™ Unit, GE Healthcare Life Sciences, Piscataway, NJ, USA) (1.2 mA/cm 2 ; 1 h 30 min) as described by Bjerrum and Heegaard (1989) . The membranes were blocked with 5% skim milk in TBS (Tris 10 mM, NaCl 150 mM, pH 7.5) for 1 h. The membranes were then incubated overnight (4°C) with primary antibodies to detect the total and phosphorylated forms of ERK1/2, p38 MAPK , JNK1/2/3 and Akt at the dilutions recommended by the manufacturer. Subsequently, the membranes were incubated for 1 h at room temperature with anti-rabbit peroxidaselinked secondary antibody (1:4,000). All of the incubation steps were followed by washing three times with TBS-T (Tris 10 mM, NaCl 150 mM, Tween-20 0.1%, pH 7.5). The blots were developed with a chemiluminescent reaction. The protein bands were quantified using the Scion Image™ software (Frederick, MD, USA). The phosphorylation level of each protein was determined by the ratio of the OD of the phosphorylated band/OD of the total band. The data are expressed as a percentage of the control (considered to be 100%), and the values are presented as the mean ± SEM (Cordova et al., 2012).
Statistical analysis
Statistical significance was assessed by one-way analysis of variance (ANOVA) followed by Duncan's post-hoc test when appropriate. A value of p 6 0.05 was considered to be significant.
Results
The neurotoxicity of glutamate in hippocampal slices evaluated with the MTT reduction assay is depicted in Fig. 1A . Notably, glutamate exposure for 6 h caused a statistically significant decrease in cell viability at concentrations of 1 mM (22.27 ± 3.57%; ⁄⁄ p < 0.01) and 10 mM (26 ± 2.0%; ⁄⁄ p < 0.01). ConBr (0.1-100 lg/ml) administered alone did not change the cell viability (Fig. 1B) . Based on these results, the neuroprotective activity of ConBr lectin against glutamatergic neurotoxicity was tested in slices incubated for 6 h in the presence of 10 mM glutamate alone or in the presence of increasing doses of ConBr (0.1-100 lg/ml). The results (Fig. 1C) demonstrate that glutamate (10 mM) decreased the slices' viability (30 ± 2.7%; ⁄⁄⁄ p < 0.001) and ConBr at a concentration of 10 lg/ml attenuated the cytotoxicity produced by glutamate (14.28 ± 1.6%; # p < 0.05 vs. glutamate). Moreover, the glutamate neurotoxicity and the neuroprotective effect of ConBr can be visualized in the slices stained with MTT (Fig. 1D) . In this set of experiments, the MTT was not dissolved with DMSO, and the slices were observed with optical microscopy. Therefore, the dehydrogenases from the viable cells reduced MTT to formazan crystals, which were then visualized as an intense violet color. Glutamate decreased the staining, while the ConBr reversed this effect, confirming the quantitative analysis shown in Fig. 1C . The data are expressed as percentage. The values are mean ± SEM of five independent experiments. ⁄⁄⁄ P < 0.001 and ⁄ P < 0.05 vs. control group.
To investigate whether the neuroprotective effect of ConBr was dependent on the carbohydrate recognition domain (CRD), ConBr was incubated with mannose (100 mM) to block the lectin's CRD. The Fig. 1E shows that ConBr previously blocked by mannose (ConBr blocked) loses its protective effect against glutamate excitotoxicity (33.28 ± 2.51%). This result indicates that the neuroprotective effect of ConBr depends on the interaction of the lectin with glycan chains via its CRD.
To assess the signaling pathways altered by glutamate exposure and determine the possible mechanisms that lead to ConBr's protective effect against glutamate excitotoxicity, the modulation of MAPKs (ERK1/2, p38 MAPK and JNK1/2/3) and PI3K/Akt were evaluated 6 h after the treatment of the hippocampal slices with glutamate (10 mM), ConBr (10 lg/mL) or glutamate (10 mM) coadministered with ConBr (10 lg/mL). The results indicated that glutamate did not alter the phosphorylation of JNK1/2/3 ( Fig. 2A and B) or ERK2 (Fig. 3) . However, glutamate significantly increased the phosphorylation of ERK1 (26.73 ± 5.11%; ⁄⁄⁄ p < 0.001; Fig. 3A and B) and p38 MAPK (35.83 ± 9.64%; ⁄ p < 0.05; Fig. 4A and B) . Nevertheless, the co-treatment with ConBr (10 lg/mL) did not prevent the increase in the phosphorylation of the MAPKs induced by glutamate (Figs. 3 and 4) . The total protein content of all of the kinases was not modified by the treatments. Furthermore, we evaluated the modulation of the PI3K/Akt pathway by glutamate and/or ConBr. The results indicate that glutamate (10 mM) decreased the phosphorylation of Akt in hippocampal slices by 24.21 ± 4.94%, ⁄ p < 0.05, and the treatment with ConBr (10 lg/mL) significantly prevented the glutamate-induced decrease in Akt phosphorylation ( # p < 0.05; Fig. 5A and B) . It is noteworthy that the total content of Akt was not modified by any treatment. Based on this finding, the possible involvement of the PI3K/Akt pathway in the neuroprotective effect of ConBr was evaluated. Therefore, the hippocampal slices were incubated with the PI3K inhibitor LY294002 (10 lM), and the cell viability was analyzed after glutamate, ConBr or glutamate/ConBr treatment. Notably, in the presence of a PI3K inhibitor (LY294002) the neuroprotective effect of ConBr was abolished (Fig. 5C ). LY294002 alone (10 lM) did not change the cell viability (Fig. 5C ).
Discussion
The present study demonstrates that ConBr protects against glutamatergic neurotoxicity in vitro. ConBr, a mannose/glucosespecific lectin, was able to prevent the glutamate-dependent impairment of cell viability in hippocampal slices by a mechanism involving the PI3K/Akt pathway. Previous studies from our group demonstrated the beneficial actions of ConBr in the function of the CNS, including: (i) an antidepressant-like effect in the forced swimming test (FST) by a mechanism dependent on its interaction with the serotoninergic, noradrenergic and dopaminergic systems (Barauna et al., 2006) ; and (ii) the neuroprotection against seizures and hippocampal cell death caused by quinolinic acid (QA) injected intracerebroventricularly (Russi et al., 2012) . Therefore, the present data reinforce the evidence that ConBr is neuroprotective.
The results clearly indicate that glutamate impairs the hippocampal cell viability and ConBr (10 lg/mL) reverses this effect. In addition, our findings indicate that the interaction of ConBr with glycans at the cell surface is a fundamental step in producing neuroprotection. This conclusion is supported by the fact that the blockage of the CRD with mannose counteracted the neuroprotective effect of ConBr against glutamate excitotoxicity. Endogenous brain lectins have been recognized as potential cell modulators (Dube and Bertozzi, 2005; Endo, 2005; Liu and Rabinovich, 2005; Qu et al., 2011) . However, their specific functional roles in the CNS regarding the modulation of synaptic activity and neuroplasticity are not yet clear (Marschal et al., 1989; Dube and Bertozzi, 2005; Endo, 2005; Qu et al., 2011) . Therefore, the present study involving the application of a plant lectin is particularly important, because it provides evidence concerning the interactions of glycan chains with lectins as an additional mechanism that might be involved in neuroprotection. It is well known that excessive glutamate in the synaptic cleft causes neuronal dysfunction and degeneration, a phenomenon implicated in many pathological processes such as ischemia, traumatic brain injury, seizures and chronic neurodegenerative diseases (Lau and Tymianski, 2010) . The NMDA receptor, the main receptor involved in glutamate excitotoxicity, is a glycoprotein that displays mannose residues within the structure of the glycan chains on the extracellular domain. Previous studies have suggested that these receptors are a potential target for the mannose/glucose-specific lectin ConBr because the lectin blocked the (10 lM), on the neuroprotective effect of ConBr against the neurotoxicity of glutamate on hippocampal slices. For this assay, hippocampal slices were incubated for 6 h in Krebs saline/DMEM buffer alone (control) or in the presence of glutamate 10 mM, or glutamate 10 mM plus ConBr 10 lg/mL or glutamate 10 mM plus ConBr 10 lg/mL with LY294002 (10 lM). The cell viability was assessed by MTT assay.
Data are expressed as percentage of control. The values are mean ± SEM of six independent experiments performed in triplicate.
⁄⁄⁄ P < 0.001 vs. control; # P < 0.05 vs. glutamate 10 mM and $$$ P < 0.001 vs. ConBr.
neurotoxicity of the NMDA agonist QA (Russi et al., 2012 (Molz et al., 2008b) .
To investigate the alterations of cell signaling pathways by glutamate and the possible involvement of these pathways in the neuroprotective effect attained by ConBr, the modulation of MAPKs and PI3K/Akt was evaluated. We previously demonstrated that glutamate can cause the impairment of cell viability and may induce apoptosis in hippocampal slices by a mechanism dependent on ionotropic receptors and p38 MAPK activation (Molz et al., 2008b) .
Moreover, the ERK signaling pathway may play a detrimental role during oxidative neuronal injury, cerebral ischemia, brain trauma and neurodegenerative diseases (Chu et al., 2004 (Choudhari et al., 2007; Jing et al., 2012) . Akt is involved in proliferation, differentiation and the protection from apoptosis that promotes cell survival (Brazil and Hemmings, 2001; Kim et al., 2004) . Recently, Molz et al. (2011) showed that guanosine protects hippocampal slices by a mechanism that involves the PI3K/Akt/GSK3b (Ser9) pathway and prevents glutamate-induced neurotoxicity. Moreover, it has been shown that glutamate excitotoxicity may decrease PI3K/Akt activation and that neuroprotective compounds may reverse this effect (Chuang et al., 2011; Dal-Cim et al., 2011; Lee et al., 2012; Sun et al., 2012) . Therefore, our results agree with these previous studies and demonstrate that glutamate induces a decrease in Akt phosphorylation and ConBr reverses this effect. Moreover, the PI3K inhibitor LY294002 abrogated the neuroprotective effect of ConBr. These results suggest that ConBr acts via a PI3K/Akt-dependent pathway to reverse glutamatergic neurotoxicity.
In conclusion, our findings confirm that ConBr, a mannose/glucose lectin, is a protein with neuroprotective effects against glutamate excitotoxicity. The mechanism involved in the action of the lectin has not been fully elucidated but likely involves the PI3K/ Akt pathway. Because the NMDA receptor subunits (NR1 and NR2) are glycosylated in the N-terminal extracellular domain (Everts et al.,1997; Clark et al., 1998) , it will be valuable in future studies to address the capability of ConBr to modulate NMDA receptors as a result of the interaction of this lectin with those oligosaccharide chains.
